Esperion posts updated corporate presentation; no specific details provided

Esperion Therapeutics, Inc.

Company filed 8-K noting October 2025 corporate presentation posted to investor page.
Exhibit 99.1 is the corporate presentation, but its content was not disclosed in this filing.
No financial or strategic updates are available from the filing text or exhibit excerpt.
Investors should review the presentation at esperion.com/investors-media for material information.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.